Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
NCT01164904
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Amg 181
Sponsor
Amgen